The Multinational Force and Observers in Sinai is a 13-nation international peacekeeping organization with the mission to implement the security provisions of the 1979 Egyptian-Israeli Treaty of Peace and continues today after approximately four decades. Despite not having significant changes to its core mission of force health protection, the medical team has recently evolved to face several challenges, with a coronavirus pandemic and a fatal helicopter crash. This article describes the medical challenges and experiences of the medical team from August 2019 to December 2020, highlighting changes from previous years. This article also updates three previous articles on the subject published in Military Medicine in 1983, 1991, and 2003.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083763PMC
http://dx.doi.org/10.1093/milmed/usab109DOI Listing

Publication Analysis

Top Keywords

multinational force
8
force observers
8
medical team
8
medical
4
medical support
4
support sinai
4
sinai multinational
4
observers update
4
update 2020
4
2020 multinational
4

Similar Publications

Some research has studied the carbon footprints of the multinational enterprises (MNEs) in the global value chains (GVCs). However, currently there are few studies have studied the carbon footprints of the foreign invested firms (FIFs) distributed in different provinces in China's domestic value chains (DVCs). This paper has used China's inter-provincial input-output table distinguishing domestically owned enterprises (DEs), Hong Kong, Macao, and Taiwan (HMTs) invested enterprises and other foreign invested enterprises (FIEs) to study the carbon footprints of the FIFs in China's DVCs and further analyzed the driving factors of the carbon footprints change.

View Article and Find Full Text PDF
Article Synopsis
  • Global uncertainties have led Western nations to undertake evacuations, exemplified by France's Operation SAGITTAIRE in Sudan during a civil war in April 2023, which involved a sophisticated multi-modal evacuation of over 1,000 individuals from 84 nationalities.
  • The operation involved special forces and medical teams, functioning around the clock for 96 hours without fatalities, executing various surgical procedures and utilizing the Joint Medical Surgical Center in Djibouti as a key medical facility.
  • The findings from the operation stress the necessity of a robust health support system for such military interventions, advocating for a comprehensive approach in Non-combatant Evacuation Operations as part of French military doctrine.
View Article and Find Full Text PDF

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology.

ESMO Open

October 2024

Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London; Division of Clinical Studies, The Institute of Cancer Research, London, UK. Electronic address:

Background: Burnout in health care professionals (HCPs) results from exposure to psychosocial risks at work. Left unaddressed, burnout can lead to chronic health problems, increased staff turnover, reduced work hours, absenteeism, and early retirement from clinical practice, thus impacting patient care. The European Society for Medical Oncology (ESMO) Resilience Task Force (RTF) was established in December 2019 to support the well-being of oncology HCPs globally.

View Article and Find Full Text PDF
Article Synopsis
  • The study is a cross-sectional survey combined with a systematic literature review aimed at evaluating the usage of tobramycin powder as a topical antibiotic in lumbar spine surgery.
  • A survey among 231 surgeons showed that only 1.7% used tobramycin, while a systematic review found two studies indicating it might reduce infections but also showed a shift in the types of bacteria.
  • The conclusion states that tobramycin is not widely used among spine surgeons, and there's insufficient evidence to recommend its routine use in preventing surgical site infections (SSI).
View Article and Find Full Text PDF

Aims: Economic studies have found that public support of basic medical research provides important long-term benefits. In response to suggestions that private pharmaceutical research and development (R&D) funding could be totally replaced by public funding, we investigate the economic implications of such a substitution in funding roles that maintain the recent pace of pharmaceutical innovation.

Materials And Methods: Total lifecycle R&D costs were estimated using the latest available R&D expenditures per novel molecule entering clinical trials, likelihood of approval, pre-clinical and post-approval expenditures, using a published survey and a review of publicly available financial accounts from US-listed multinational developers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!